# US Inhaled Insulin Therapeutic Choice Questionnaire Study

> **NCT00139763** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 740 (—)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **PROCEDURE:** Educational Materials

## Key facts

- **NCT ID:** NCT00139763
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** —
- **Final completion:** 2006-03
- **Target enrollment:** 740 (—)
- **Last updated:** 2007-03-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00139763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00139763, "US Inhaled Insulin Therapeutic Choice Questionnaire Study". Retrieved via MORVS 2026-10-25 from https://api.morvs.ai/clinical/NCT00139763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*